Pharmazac announces Rasagiline generic
November 2, 2023Pharmazac announces Rosuvastatin
November 2, 2023Pharmazac announces Nitastin

Pharmazac has released the new product Nitastin
20mg film coated tablet for treatment of heart disease
In addition to the hypolipidemic actions Nitastin has beneficial effects in endothelial dysfunction, on the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties.
There is evidence that Nitastin improves endothelial function within 30 days of therapy.
Related News
November 2, 2023
We are investing in our new pharmaceuticals manufacturing site.
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
November 2, 2023
Pharmazac launched the new product Zaolin/Vinorelbin
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
November 2, 2023
We are exhibiting and partnering
With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more […]
November 2, 2023
We are becoming a manufacturer and key player in radiopharmaceuticals
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
